Therapeutic device to be applied to the skin in correspondence with the primary and secondary nerve endings of tendons, muscles, dermatomes and nerve endings, whose painful and inflammatory neuro-muscular and postural remodulation is to be favoured, including at least one laminar support element, and a mixture given by the combination of at least two types of quantum dots, including the following: - Graphene quantum dots with a fluorescence indicatively corresponding to: excitation wavelength, λex, 350 nm; emission wavelength, λem, 445 nm, full width at half maximum, FWHM, 65 nm, quantum yield >65%; - Graphene quantum dots blue luminescent with a fluorescence approximately corresponding to: excitation wavelength, λex, 350 nm; emission wavelength, λem, 445 nm±10 nm, full width at half maximum, FWHM, 75 nm, quantum yield ≥20% - Graphene quantum dots cyan luminescent with a fluorescence indicatively corresponding to: emission wavelength, λem, 475-495 nm, full width at half maximum, FWHM, 70 nm, quantum yield >17% - Graphene quantum dots aqua green luminescent with a fluorescence indicatively corresponding to: excitation wavelength, λex, 485 nm; emission wavelength, λem, 530 nm±10 nm, full width at half maximum, FWHM, 80 nm, quantum yield ≥17%; - Perovskite quantum dots oleic acid and oleylamine coated with a fluorescence indicatively corresponding to: emission wavelength, λem, 480 nm; - CdTe core-type quantum dots COOH functionalized showing a fluorescence indicatively corresponding to: emission wavelength, λem, 710 nm, quantum yield >15%; - CdS/ZnS core-shell type quantum dots oleic acid functionalised showing a fluorescence indicatively corresponding to: maximum wavelength, λmax, 385 nm, emission wavelength, λem, 400 nm±10 nm, quantum yield >50%; - CdS/ZnS core-shell type quantum dots oleic acid functionalised showing a fluorescence indicatively corresponding to: maximum wavelength, λmax, 405 nm, emission wavelength, λem, 425 nm±10 nm; where said support consists of a laminar element of transparent material at a reference wavelengths between 280 nm and 740 nm, and preferably between 350 nm and 530 nm, a first side of the laminar support can be put in contact with the skin of the person whose dysfunction or inflammatory pathology is to be treated, and being placed on the opposite side of the first side of said support, or incorporated or diffused in the laminar element itself, a mixture of at least two of said quantum dots, with a concentration of 1 mg/cm 2 to 100 mg/cm 2, capable of emitting photons in the reference wavelength, with an intensity of between 0.1 mW/cm 2 and 0.5 mW/cm 2, and preferably between 0.2 mW/m 2 and 0.4 mW/cm 2, when stimulated by at least one infrared, visible light or ultraviolet electromagnetic radiation. - Graphene quantum dots with a fluorescence indicatively corresponding to: excitation wavelength, λex, 350 nm; emission wavelength, λem, 445 nm, full width at half maximum, FWHM, 65 nm, quantum yield >65%; - Graphene quantum dots blue luminescent with a fluorescence approximately corresponding to: excitation wavelength, λex, 350 nm; emission wavelength, λem, 445 nm±10 nm, full width at half maximum, FWHM, 75 nm, quantum yield ≥20% - Graphene quantum dots cyan luminescent with a fluorescence indicatively corresponding to: emission wavelength, λem, 475-495 nm, full width at half maximum, FWHM, 70 nm, quantum yield >17% - Graphene quantum dots aqua green luminescent with a fluorescence indicatively corresponding to: excitation wavelength, λex, 485 nm; emission wavelength, λem, 530 nm±10 nm, full width at half maximum, FWHM, 80 nm, quantum yield ≥17%; - Perovskite quantum dots oleic acid and oleylamine coated with a fluorescence indicatively corresponding to: emission wavelength, λem, 480 nm; - CdTe core-type quantum dots COOH functionalized showing a fluorescence indicatively corresponding to: emission wavelength, λem, 710 nm, quantum yield >15%; - CdS/ZnS core-shell type quantum dots oleic acid functionalised showing a fluorescence indicatively corresponding to: maximum wavelength, λmax, 385 nm, emission wavelength, λem, 400 nm±10 nm, quantum yield >50%; - CdS/ZnS core-shell type quantum dots oleic acid functionalised showing a fluorescence indicatively corresponding to: maximum wavelength, λmax, 405 nm, emission wavelength, λem, 425 nm±10 nm;